In 2017, the AACR reported another year of positive financial growth. This financial stability enables the AACR to comprehensively meet the challenges of the cancer problem. Operating revenues increased 27% to $113 million and total expenditures closely matched revenues. The net impact of revenues and expenses resulted in an operating surplus of $3.8 million. As outlined in this report, several major projects were launched in 2017, and the AACR was able to outperform the budget through successful programming, revenue growth, and prudent financial management.

Non-operating activities are primarily related to long-term investments. The AACR’s investments provided strong returns in the amount of $11.3 million in 2017 and outperformed comparable market indexes.

The results of the combined operating and non-operating activities resulted in a net surplus of $15.1 million, which enabled the AACR’s unrestricted net assets to grow to $75.8 million. This important source of income ensures continued investment in the programs that will accelerate progress toward the prevention and cure of cancer in accordance with AACR’s strategic plan.